Rafoxanide
![]() | |
| Names | |
|---|---|
| Preferred IUPAC name
N-[3-Chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide | |
| Other names
Rafoxanid, raphoxanide
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.041.029 |
| EC Number |
|
| KEGG | |
| MeSH | D011888 |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C19H11Cl2I2NO3 | |
| Molar mass | 626.01 g/mol |
| Appearance | Slight yellowish-brown injectable solution and white oral solution |
| In oily solutes | |
| Pharmacology | |
| QP52AG05 (WHO) | |
| Hazards | |
| Occupational safety and health (OHS/OSH): | |
Main hazards
|
Has low safety index (6 times as normal dose) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
Rafoxanide is a salicylanilide used as an anthelmintic.[1] It is most commonly used in ruminant animals to treat adult liver flukes of the species Fasciola hepatica and Fasciola gigantica.[1]
